14 June 2023
12:00 PM - 1:30 PM EST
Registration for this event has closed

Digital Health: How AI & Personalized Medicine is Changing Healthcare Delivery

Digital Health – technologies like artificial intelligence, personalized medicine and patient provided digital health information – it is all around us. We see it every day, from making appointments on-line to tracking our steps on a health app from a personal device. How will it affect you, your treatment, and the health industry as a whole? Is the emergence of digital health going to bring long-expected change or is there still more work to be done to tap its full potential? What’s next?

Join us for a 90 min. Q&A discussion presented by Women in Science (WIS) where we tap into the ideas and knowledge of experts in the Digital Health industry. These visionaries understand the current state of digital health and see in it a future that could harness these powerful technologies for the greater good of healthcare for all.

Moderator: Joy Sacmar, VP Regulatory, Robotics and Digital Solutions at Johnson and Johnson
Panelist: Iddo Leshem, VP, Head of Commercialization for Digital Health at Bristol Myers Squibb
Panelist: Ainslie Forbes, ED, Head of Digital Health R&D at Otsuka Pharmaceutical Companies
Panelist: Astrid Scherer, VP, Head of Product Development & Performance Excellence, Clinical Development & Operations, Bayer AG
Panelist: Leslie Anne Fendt, PhD, Integrated Solutions Program Lead, Remote Vision Monitoring, Roche
Panelist: Anastasia Christianson, VP, Global Head of AI, ML, Analytics and Data at Pfizer

Interested in joining the HBA Women in Science affinity group to engage with this community of thought leaders? HBA members can join on our website.

Registration information
Event is open to: HBA Members and Non-members

Learning Objectives

During this session, you will
· Expand your understanding of how digital health fits in today and tomorrow’s delivery of healthcare.
· Develop a vision of the potential of digital health to improve clinicians’ delivery of care and patient outcomes.
· List ways of protecting health data and maintaining quality control while these new technologies are being developed and implemented in healthcare.

Featured Speakers

Anastasia Christianson
VP, Global Head of AI, ML, Analytics and Data, Pfizer Inc.
Leslie Anne Fendt
Integrated Solutions Program Lead, Remote Vision Monitoring, Roche Genentech
Ainslie Forbes
Executive Director, Head of Digital Health R&D, Otsuka America Pharmaceutical, Inc.
Iddo Leshem
Head of Commercialization, Digital Health , Bristol Myers Squibb
Joy Sacmar
VP, Regulatory Affairs, Robotics & Digital , Johnson & Johnson Medical Devices, A Johnson & Johnson Company
Astrid Scherer
Head of Product Development & Performance Excellence, Bayer AG

Event Sponsor


Regular Registration$10.00 / €10.00$20.00 / €20.00
Sponsor Employee Registration$10.00 / €10.00$10.00 / €10.00

Members receive up to 50 percent discount

Event Policies

Photography Policy
By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.

COVID-19 Policy
The HBA requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.

By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any HBA volunteers participating in the activity will act individually and will not represent the HBA. As a condition to my participation the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.

Special Needs Policy
The HBA will make reasonable modifications to policies and programs to ensure that people with special needs can enjoy all of its programs. Contact us if you require special accommodations for this event.